LONDON -- Stock index futures at 7 a.m. EDT indicate that the Dow Jones Industrial Average (DJINDICES: ^DJI ) may open up by a meager two points this morning, while the S&P 500 (SNPINDEX: ^GSPC ) may open a quarter-point higher. The CNN Fear & Greed Index has slowed its rise and remains unchanged at 87, signifying "extreme greed."
European markets were mixed this morning, but the FTSE 100 edged higher and broke through the 6,700 barrier for the first time since October 2007. The FTSE was helped by new Japanese GDP figures showing that Japan's economy grew by 0.9% in the first quarter of the year, suggesting that Prime Minister Shinzo Abe's monetary-easing policies may be starting to stimulate growth.
In the U.S., investors are likely to focus on several items of key economic data that are due for release today. Starting at 8:30 a.m. EDT, initial jobless claims are expected to have risen to 330,000 last week, up slightly from 323,000 the previous week. Also due at 8:30 a.m. EDT, the consumer price index is expected to show that prices fell by 0.3% in April after falling by 0.2% in March. Forecasts suggest that 965,000 housing starts were recorded in April, down slightly from 1.04 million in March, while 943,000 building permits may have been issued in April, up from 907,000 in March. Finally, at 10 a.m. EDT, the Philadelphia Fed manufacturing survey is expected to come in at two for May, up from 1.3 in April.
Top Insurance Stocks To Watch For 2015: Coronado Biosciences Inc (CNDO)
Coronado Biosciences, Inc., incorporated on June 28, 2006, is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. The Company�� two principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201 (TSO) a biologic comprising of the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases, such as Crohn�� disease (Crohn��), ulcerative colitis (UC) and multiple sclerosis (MS), and CNDO-109, a compound that activates natural killer (NK) cells of the immune system to seek and destroy cancer cells, for the treatment of acute myeloid leukemia (AML). In January 2011, the Company acquired the OvaMed GmbH License.
TSO
TSO is the microscopic eggs of a parasitic helminth, or worm, that is found in pigs. In September 2011, the Company filed an Investigational New Drug Application (IND) with the United States Food and Drug Administration (FDA) and it initiated a single dose, dose escalation study in patients with Crohn�� in February 2012. The Phase 1 clinical trial was a multi-center, sequential dose-escalation, double-blind, placebo-controlled study, the primary objective of which was to evaluate the safety and tolerability of TSO. The trial enrolled 36 patients with Crohn�� ranging in age from 20 to 54 with an equal distribution of male and female patients in three single dose cohorts of orally administered 500, 2500 and 7500 ova. Each cohort had 12 patients, with nine patients receiving TSO and three receiving placebo.
CNDO-109
CNDO-109 is a lysate (disrupted CTV-1 cells, cell membrane fragments, cell proteins and other cellular components) that activates donor NK cells. CTV-1 is a leukemic cell line recently re-classified as a T-cell acute lymphocytic leukemia (ALL). The Company has worldwide rights to develop and commercialize CNDO-109 activated NK cells for the treatment of cancer fro! m UCLB. In February 2012, the Company submitted an IND for the CNDO-109 activated NK cell product in the United States. The treatment of patients with CNDO-109 activated NK cells involves several steps. The activated NK cells are infused into the patient after resting NK cells are incubated with CNDO-109 for at least eight hours. Preparation of CNDO-109 activated NK cells takes about 24 hours from start to finish.
The Company competes with Centocor Ortho Biotech Inc.�� Remicade , UCB S.A.�� Cimzia, Abbott Laboratories��Humira, Biogen Idec�� Avonex, Bayer Healthcare Pharmaceuticals��Betaseron, Teva Pharmaceuticals Industries, Ltd.�� Copaxone and Novartis AG�� Gilenya.
Advisors' Opinion:- [By CRWE]
Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, reported that it has filed a registration statement with the Securities and Exchange Commission for a proposed public offering of 2,000,000 shares of its common stock. All shares proposed to be included in the offering will be sold by the company.
- [By Roberto Pedone]
Coronado Biosciences (CNDO), a clinical stage biopharmaceutical company, focuses on the development of immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. This stock closed up 2.7% to $9.13 in Tuesday's trading session.
Tuesday's Range: $8.85-$9.58
52-Week Range: $4.00-$12.70
Tuesday's Volume: 1.31 million
Three-Month Average Volume: 419,038From a technical perspective, CNDO trended up here right above some near-term support at $8.79 with heavy upside volume. This move is starting to push shares of CNDO within range of triggering a near-term breakout trade. That trade will hit if CNDO manages to take out some near-term overhead resistance levels at $9.60 to $10.20 and then once it takes out more resistance at $10.35 with high volume.
Traders should now look for long-biased trades in CNDO as long as it's trending above its 50-day at $8.52 and then once it sustains a move or close above those breakout levels with volume that hits near or above 419,038 shares. If that breakout hits soon, then CNDO will set up to re-test or possibly take out its next major overhead resistance levels at $11 to $11.81. Any high-volume move above those levels will then put its all-time high at $12.70 into range for shares of CNDO.
Top 5 Japanese Companies To Invest In Right Now: Novartis AG (NOVN)
Novartis AG provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. Its portfolio includes medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. It has five segments: Pharmaceuticals, which include patent-protected prescription medicines; Alcon, which include surgical, ophthalmic pharmaceutical and vision care products; Sandoz, which include generic pharmaceuticals; vaccines and diagnostics, which include human vaccines and blood-testing diagnostics, and consumer health, which include over-the-counter medicines (OTC) and Animal Health. In February 2014, it acquired CoStim Pharmaceuticals, Inc. Advisors' Opinion:- [By Corinne Gretler]
Novartis AG (NOVN) climbed 1.3 percent after saying a psoriasis treatment met all its objectives in a clinical study. Lloyds (LLOY) Banking Group Plc advanced 3.8 percent after a person with knowledge of the matter said a former Standard Chartered Plc executive may mount a bid for a stake in the U.K.�� biggest mortgage lender. TGS Nopec Geophysical ASA declined the most since May 2012 after cutting its full-year revenue guidance.
- [By Corinne Gretler]
Novartis AG (NOVN) climbed 2 percent to 69.25 Swiss francs after raising its full-year forecasts. Sales will increase at a low-to mid-single-digit percentage rate in constant currencies, and core operating income will match or exceed the previous year, Europe�� biggest drugmaker said. In July, the company forecast a low-single-digit percentage decline in earnings in 2013, with sales rising at a similar rate.
Top 5 Japanese Companies To Invest In Right Now: Dean Foods Company(DF)
Dean Foods Company, together with its subsidiaries, operates as a food and beverage company in the United States. It operates in two segments, Fresh Dairy Direct-Morningstar and WhiteWave-Alpro. The Fresh Dairy Direct-Morningstar segment manufactures, markets, and distributes various branded and private label dairy case products, including cream, ice cream mix, and ice cream novelties; creamers and other extended shelf life fluids; yogurt, cottage cheeses, sour creams, and dairy-based dips; fruit juices, fruit-flavored drinks, iced teas, and water; half-and-half and whipping creams; and items for resale, such as butter, cheese, eggs, and milk shakes. This segment sells its dairy case products to retailers, distributors, foodservice outlets, educational institutions, and governmental entities. The WhiteWave-Alpro segment manufactures, develops, markets, and sells various branded dairy and dairy-related products, such as milk and other dairy products; organic dairy products; plant-based beverages, such as soy, almond, and coconut milks; and soy food products, coffee creamers, and creamers and fluid dairy products. It also provides branded soy-based beverages and food products in Europe under the Alpro and Provamel brands. This segment sells its products to various customers, including grocery stores, club stores, natural foods stores, mass merchandisers, convenience stores, drug stores, and foodservice outlets. The company was formerly known as Suiza Foods Corporation and changed its name to Dean Foods Company on December 21, 2001 as a result of merger between the former Dean Foods Company and Suiza Foods Corporation. Dean Foods Company was founded in 1995 and is headquartered in Dallas, Texas.
Advisors' Opinion:- [By FinanceGuru]
In response to this shift in consumer preferences, Dean Foods (DF) was quick to spin off its fast-growing WhiteWave division, which makes Horizon Organic Milk and Silk soy products, into WhiteWave Foods (WWAV). WhiteWave Foods competes with the likes of Hain Celestial (HAIN) and Blue Diamond Growers in the plant-based beverages market, but is it a good buy?
- [By Lisa Levin]
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Most Popular Will Publix Try To Acquire Whole Foods? Apple Split Windfall For Option Traders & Brokerages - [By Paul Ausick]
Stocks on the move: Catalyst Pharmaceutical Partners Inc. (NASDAQ: CPRX) is up about 40% at $1.98 after its firdapse drug treatment for certain kinds of muscle weakness was designated a breakthrough therapy by the FDA. Food maker Dean Foods Inc. (NYSE: DF) held a 1-for-2 reverse stock split this morning and the shares are up about 95%, as might be expected.
- [By Michael Lewis]
After being spun off from its parent company, Dean Foods (NYSE: DF ) , health-oriented food purveyor White Wave Foods (NYSE: WWAV ) offered the market a nearly pure play on plant-based food items, one of the fastest growing areas within the industry. The spinoff was originally priced rather high, though the company is certainly growing. Now, the secondary offering is coming to a close and the spinoff is nearly complete while the company posts strong preliminary results. Even at its premium price, is White Wave Foods a buy after the spin-off is completed?
Top 5 Japanese Companies To Invest In Right Now: Powershares High Yield Equity Dividend (PEY)
PowerShares High Yield Equity Dividend Achievers Portfolio is based on the Mergent Dividend Achievers 50 Index. The Mergent Dividend Achievers 50 Index seeks to deliver current income and capital appreciation. It comprises the fifty highest yielding companies with at least 10 years of consecutive dividend increases.
The Index�� high dividend yield approach provides exposure to deep value companies while the long-term dividend growth requirement attempts to minimize exposure to distressed value companies. The yield weighted portfolio is rebalanced quarterly and reconstituted annually.
Advisors' Opinion:- [By Chuck Saletta]
If that savings target seems too high, your options include either working longer (to keep the length of your retirement shorter) or investing more aggressively. For instance, the PowerShares High Yield Dividend Achievers (NYSEMKT: PEY ) invests in higher-yielding companies with decent histories of raising their payouts. That ETF currently yields more than the Vanguard bond fund, and the companies in the PowerShares ETF have the potential to raise their payouts as they grow.
- [By Chuck Saletta]
PowerShares High Yield Dividend Achievers (NYSEMKT: PEY )
50 higher yielding members of the dividend achievers index�
No comments:
Post a Comment